Cholera Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 50 pages | ID: CC1981D1D868EN
VPAResearch

Abstracts

Cholera Drug pipeline report- 2020 is an annual R&D review of Cholera pipeline candidates. The report presents the current status of all major Cholera therapeutic compounds. Detailed insights into Cholera pipeline development, current status, companies, drug profiles and Cholera preclinical and clinical trials are included.

2020 Cholera Pipeline Market Insights
Cholera disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Cholera therapies, pipeline by phase and others are included.

Cholera pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Cholera Therapeutic Drug candidates
Both active and inactive Cholera pipeline drug candidates are included in the report

Cholera Clinical Trials and preclinical Studies
Cholera In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Cholera pipeline market developments
Cholera Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Cholera pipeline companies in active development
The report analyzes Cholera pipeline of the below companies-

Akthelia Pharmaceuticals Ltd, Astellas Pharma Inc , Beijing Minhai Biotechnology Co Ltd, Global BioLife Inc Ltd, Hilleman Laboratories, Napo Pharmaceuticals Inc, OstriGen Inc

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
7 Companies investing in Cholera pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Cholera pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included

Contents

1. CHOLERA PIPELINE MARKET INSIGHTS, 2020

1.1 Cholera Disease Overview
1.2 Cholera Drug Pipeline Snapshot, 2020
  1.2.1 Cholera Pipeline Drugs by Phase
  1.2.2 Cholera Pipeline Drugs by Company
  1.2.3 Cholera Pipeline Drugs by Mechanism of Action
  1.2.4 Cholera Pipeline Drugs by Route of Administration

2. CHOLERA COMPANY WISE PIPELINE DETAILS

Akthelia Pharmaceuticals Ltd Cholera Pipeline Drugs
  Company Profile
  Drug Candidate Details
Astellas Pharma Inc Cholera Pipeline Drugs
  Company Profile
  Drug Candidate Details
Beijing Minhai Biotechnology Co Ltd Cholera Pipeline Drugs
  Company Profile
  Drug Candidate Details
Global BioLife Inc Ltd Cholera Pipeline Drugs
  Company Profile
  Drug Candidate Details
Hilleman Laboratories Cholera Pipeline Drugs
  Company Profile
  Drug Candidate Details
Napo Pharmaceuticals Inc Cholera Pipeline Drugs
  Company Profile
  Drug Candidate Details
OstriGen Inc Cholera Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. CHOLERA DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. CHOLERA PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts